111 related articles for article (PubMed ID: 12552813)
41. Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo.
Zhang Y; Song S; Liu C; Wang Y; Xian X; He Y; Wang J; Liu F; Sun S
Cell Immunol; 2007 May; 247(1):18-27. PubMed ID: 17707782
[TBL] [Abstract][Full Text] [Related]
42. Immune response induced by a different combined immunization of HBsAg vaccine.
Wu T; Chen M; Ou SH; Cheng T; Zhang J; Xia NS
Intervirology; 2007; 50(5):336-40. PubMed ID: 17700028
[TBL] [Abstract][Full Text] [Related]
43. High-level expression of codon optimized foot-and-mouth disease virus complex epitopes and cholera toxin B subunit chimera in Hansenula polymorpha.
Song H; Zhou L; Fang W; Li Y; Wang X; Fang H; Li X; Wu M; Qiu B
Biochem Biophys Res Commun; 2004 Feb; 315(1):235-9. PubMed ID: 15013451
[TBL] [Abstract][Full Text] [Related]
44. Cationic transfersomes based topical genetic vaccine against hepatitis B.
Mahor S; Rawat A; Dubey PK; Gupta PN; Khatri K; Goyal AK; Vyas SP
Int J Pharm; 2007 Aug; 340(1-2):13-9. PubMed ID: 17446015
[TBL] [Abstract][Full Text] [Related]
45. Plant-based vaccines against human hepatitis B virus.
Shchelkunov SN; Shchelkunova GA
Expert Rev Vaccines; 2010 Aug; 9(8):947-55. PubMed ID: 20673016
[TBL] [Abstract][Full Text] [Related]
46. Immune responses to recombinant Mycobacterium smegmatis expressing fused core protein and preS1 peptide of hepatitis B virus in mice.
Yue Q; Hu X; Yin W; Xu X; Wei S; Lei Y; Lü X; Yang J; Su M; Xu Z; Hao X
J Virol Methods; 2007 Apr; 141(1):41-8. PubMed ID: 17197041
[TBL] [Abstract][Full Text] [Related]
47. Monoclonal antibody against non-dominant epitopes of HBV e Ag was raised by antigen-antibody co-immunization.
Yan LC; Jing CY; Huang CF; Ji YY; Yao G; Cai XF; Sun B
J Biotechnol; 2007 May; 129(4):620-7. PubMed ID: 17408795
[TBL] [Abstract][Full Text] [Related]
48. Different immunogenicity of H-2 Kb-restricted epitopes in natural variants of the hepatitis B surface antigen.
Schirmbeck R; Böhm W; Fissolo N; Melber K; Reimann J
Eur J Immunol; 2003 Sep; 33(9):2429-38. PubMed ID: 12938219
[TBL] [Abstract][Full Text] [Related]
49. Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen.
Lobaina Y; Palenzuela D; Pichardo D; Muzio V; Guillén G; Aguilar JC
Mol Immunol; 2005 Feb; 42(3):289-94. PubMed ID: 15589316
[TBL] [Abstract][Full Text] [Related]
50. CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine.
Eliasson DG; El Bakkouri K; Schön K; Ramne A; Festjens E; Löwenadler B; Fiers W; Saelens X; Lycke N
Vaccine; 2008 Feb; 26(9):1243-52. PubMed ID: 18243429
[TBL] [Abstract][Full Text] [Related]
51. Immunogenic properties of the Salmonella atypical fimbriae in BALB/c mice.
Strindelius L; Folkesson A; Normark S; Sjöholm I
Vaccine; 2004 Mar; 22(11-12):1448-56. PubMed ID: 15063568
[TBL] [Abstract][Full Text] [Related]
52. [Effect of exogenous epitopes of helper T lymphocyte on humoral immunity of HBV S gene DNA immunity].
Peng XM; Xie DY; Gu L; Huang YS; Gao ZL; Yao JL
Zhonghua Yi Xue Za Zhi; 2003 Feb; 83(3):232-6. PubMed ID: 12812669
[TBL] [Abstract][Full Text] [Related]
53. Antigenicity and immunogenicity of the immunodominant region of hepatitis B surface antigen displayed on bacteriophage T7.
Tan GH; Yusoff K; Seow HF; Tan WS
J Med Virol; 2005 Dec; 77(4):475-80. PubMed ID: 16254965
[TBL] [Abstract][Full Text] [Related]
54. Production in Pichia pastoris and characterization of genetic engineered chimeric HBV/HEV virus-like particles.
Li HZ; Gang HY; Sun QM; Liu X; Ma YB; Sun MS; Dai CB
Chin Med Sci J; 2004 Jun; 19(2):78-83. PubMed ID: 15250239
[TBL] [Abstract][Full Text] [Related]
55. Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.
Cong H; Gu QM; Jiang Y; He SY; Zhou HY; Yang TT; Li Y; Zhao QL
Parasite Immunol; 2005; 27(1-2):29-35. PubMed ID: 15813720
[TBL] [Abstract][Full Text] [Related]
56. Recombinant heat shock protein 65 carrying hepatitis B core antigen induces HBcAg-specific CTL response.
Yang BF; Zhao HL; Xue C; Xiong XH; Zhang W; Yao XQ; Liu ZM
Vaccine; 2007 May; 25(22):4478-86. PubMed ID: 17467856
[TBL] [Abstract][Full Text] [Related]
57. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA.
Holmgren J; Adamsson J; Anjuère F; Clemens J; Czerkinsky C; Eriksson K; Flach CF; George-Chandy A; Harandi AM; Lebens M; Lehner T; Lindblad M; Nygren E; Raghavan S; Sanchez J; Stanford M; Sun JB; Svennerholm AM; Tengvall S
Immunol Lett; 2005 Mar; 97(2):181-8. PubMed ID: 15752556
[TBL] [Abstract][Full Text] [Related]
58. A novel mucosal vaccine against foot-and-mouth disease virus induces protection in mice and swine.
Song H; Wang Z; Zheng D; Fang W; Li Y; Liu Y; Niu Z; Qiu B
Biotechnol Lett; 2005 Nov; 27(21):1669-74. PubMed ID: 16247672
[TBL] [Abstract][Full Text] [Related]
59. Mutant hepatitis B virus surface antigens (HBsAg) are immunogenic but may have a changed specificity.
Zheng X; Weinberger KM; Gehrke R; Isogawa M; Hilken G; Kemper T; Xu Y; Yang D; Jilg W; Roggendorf M; Lu M
Virology; 2004 Nov; 329(2):454-64. PubMed ID: 15518823
[TBL] [Abstract][Full Text] [Related]
60. Adjuvant effect of CIA07, a combination of Escherichia coli DNA fragments and modified lipopolysaccharides, on the immune response to hepatitis B virus surface antigen.
Song ES; Park SA; Kim SH; Cho YJ; Ahn BY; Ahn BC; Lee NG
FEMS Immunol Med Microbiol; 2007 Dec; 51(3):496-504. PubMed ID: 17877731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
